Past Papers · SAQ
Pulmonary Vasoconstriction & Inhaled Vasodilators
2026A Q12
Exam questiona) Describe the physiological factors that contribute to pulmonary vasoconstricton. Include the mechanisms involved in your answer (60% of marks). b) For each of the inhaled pulmonary vasodilators, nitric oxide and prostacyclin: i) describe the mechanism(s) of action (25% of marks) ii) outline the adverse effects (15% of marks).
CICMWrecks answer
Master answer
Master answer coming soon.
Past papers
Exam appearances
| Exam | Exact exam wording | Candidate success |
|---|---|---|
| 2026A Q12 | a) Describe the physiological factors that contribute to pulmonary vasoconstricton. Include the mechanisms involved in your answer (60% of marks). b) For each of the inhaled pulmonary vasodilators, nitric oxide and prostacyclin: i) describe the mechanism(s) of action (25% of marks) ii) outline the adverse effects (15% of marks). | 44.6% |